BINV.ST STO
BioInvent International AB (publ)
1W: +2.9%
1M: -3.2%
3M: -5.0%
YTD: -14.9%
1Y: -36.6%
3Y: +47.7%
5Y: -51.1%
kr 22.90 ($2.28)
+0.40 (+1.78%)
Weekly Expected Move ±5.8%
kr 20
kr 22
kr 23
kr 24
kr 26
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Cash Flow Trends
Operating Cash Flow
-$248M
+34.9% ▲
Capital Expenditures
$7M
+27.6% ▲
5Y CAGR: +1.6%
Free Cash Flow
-$255M
+34.7% ▲
Dividends Paid
$0
+0.0% ▲
Buybacks
$0
+0.0% ▲
Net Change in Cash
-$79M
-144.9% ▼
Cash Flow Composition
Year-over-Year Growth
View Full Cash Flow Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Operating Activities — | |||||
| Net Income | -$278M | -$51M | -$330M | -$471M | -$333M |
| Depreciation & Amort. | $15M | $15M | $17M | $11M | $20M |
| Stock-Based Comp. | $1M | $2M | $3M | $5M | $0 |
| Change in Working Capital | $17M | -$7M | -$10M | $8M | $50M |
| Other Non-Cash Items | $869K | $2M | $16M | $66M | $16M |
| Operating Cash Flow | -$246M | -$41M | -$342M | -$380M | -$248M |
| — Investing Activities — | |||||
| Capital Expenditures | -$13M | -$12M | -$13M | -$10M | -$7M |
| Acquisitions (Net) | $0 | $0 | $0 | $0 | $0 |
| Investment Purchases | -$454M | -$616M | $0 | $0 | $0 |
| Investment Sales | $0 | $0 | $73M | $574M | $187M |
| Other Investing | -$454M | -$616M | $0 | $0 | $0 |
| Investing Cash Flow | -$468M | -$629M | $60M | $564M | $180M |
| — Financing Activities — | |||||
| Net Debt Issuance | $0 | $0 | $0 | -$8M | $0 |
| Stock Repurchased | $0 | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 | $0 |
| Other Financing | -$6M | -$6M | -$8M | $0 | -$9M |
| Financing Cash Flow | $895M | $273M | $23M | -$8M | -$9M |
| Net Change in Cash | $181M | -$396M | -$255M | $175M | -$79M |
| Cash End of Period | $911M | $515M | $260M | $435M | $356M |
| Free Cash Flow | -$259M | -$54M | -$355M | -$391M | -$255M |